Sintilimab (anti-PD-1 antibody) combined with high-dose methotrexate, temozolomide, and rituximab (anti-CD20 antibody) in primary central nervous system lymphoma: a phase 2 study - Concepedia

Concepedia

Publication | Open Access

Sintilimab (anti-PD-1 antibody) combined with high-dose methotrexate, temozolomide, and rituximab (anti-CD20 antibody) in primary central nervous system lymphoma: a phase 2 study

DOI Full Paper Access

16

Citations

31

References

2024

Year

Zhiyong Zeng, Apeng Yang, Jingke Yang, Sheng Zhang, Zhen Xing, Xingfu Wang, Wenzhong Mei, Changzhen Jiang, Jun‐Fang Lin, Xiyue Wu,

Signal Transduction and Targeted Therapy

References

	Year	Citations

Page 1